Neurointerventional medicine, also known as 'interventional neuroradiology', refers to the diagnosis and treatment of central nervous system, head and neck, spinal diseases, and other conditions through the combination of percutaneous puncture catheter technology with radiological imaging. Compared to surgical procedures, neurointerventional medicine reduces risks in multiple dimensions. For example, treatment can be completed without exposing the lesion surgically, resulting in less damage, faster recovery, and reduced risks of anesthesia complications, infections, etc. Neurointerventional devices refer to a series of medical consumables used for diagnosing and treating cerebrovascular diseases around neurointerventional techniques. With continuous investment in national healthcare, improved residents' payment capabilities, and the intensification of the aging population trend, the market scale of medical consumables for interventional treatment of neurological vascular diseases in China is growing rapidly, with broad market prospects ahead. Therefore, based on research into this market, Frost & Sullivan (Frost & Sullivan) has released the 'Neurointerventional Medical Device Market Industry Research Report'.
The attachment is a summary report. If you have further research needs on the neurointerventional medical device market, please contact us:
Mr. Ma, Frost & Sullivan
Tel: (+86) 159-2139-6033
E-mail: fred.mao@frostchina.com
